Differential regulation of dopamine transporter after chronic self- administration of bupropion and nomifensine

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 1, 1997, Pages 508-513

  Tella, Srihari R ^a   Ladenheim, Bruce ^b   Cadet, Jean Lud ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID ISOPROPYL ESTER; AMFEBUTAMONE; DOPAMINE TRANSPORTER; NOMIFENSINE; VANOXERINE;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG EFFECT; DRUG SELF ADMINISTRATION; HOMEOSTASIS; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RECEPTOR UPREGULATION;

ANIMALS; BUPROPION; CARRIER PROTEINS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NOMIFENSINE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 0030924663     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. 3H]BTCP in rat caudate membranes. J. Pharmacol. Exp. Ther. 268: 1462-1475, 1994.
2. ATOR, N. A. AND GRIFFITHS, R. R.: Differential sensitivity to madozlam discriminative stimulus effects following self-administered versus response-independent midazolam. Psychopharmacology 110: 1-4, 1992.
3. BAUMANN, M. H., CHAR, G. U., DE COSTA, B. R., RICE, K. C. AND ROTHMAN, R. B.: GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat. J. Pharmacol. Exp. Ther. 271: 1216-1222, 1994.
4. BERGMAN, J., MADRAS, B. K., JOHNSON, S. E. AND SPEALMAN, R. D.: Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J. Pharmacol. Exp. Ther. 251: 150-155, 1989.
5. 125I]iodophenyl)tropane-2β-carboxylic acid isopropyl ester. Mol. Pharmacol. 47: 779-786, 1995.
6. CARBONI, K., IMPERATO, A., PEREZZANI, L. AND DI CHIARA, G.: Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28: 653-661, 1989.
7. CHURCH, W. H., JUSTICE, J. B. AND BYRD, L. D.: Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine. Eur. J. Pharmacol. 139: 345-348, 1987.
8. DENEAU, G., YANAGITA, T. AND SEEVERS, M. H.: Self-administration of psychoactive substances by the monkey: A measure of psychological dependence. Psychopharmacologia 16: 30-48, 1969.
9. 3H]mazindol binding to the dopamine transporter by a competitive mechanism: Preliminary evidence for different binding domains. Neurochem. Res. 19: 201-208, 1994.
10. DEUTSCH, H. M. AND SCHWERI, M. M.: Can stimulant binding and dopamine transport be differentiated? studies with GBR 12783 derivatives. Life Sci. 55: 115-120, 1994.
11. DWORKIN, S. I., MIRKIS, S. AND SMITH, J. E.: Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drug. Psychpharmacology 117: 262-266, 1995.
12. FERRIS, R. M. AND COOPER, B. R.: Mechanism of antidepressant activity of bupropion. J. Clin. Psychiatry Monogr. 11: 2-14, 1993.
13. GIROS, B., WANG, Y. M., SUTER, S., MCLESKEY, S. B., PIFL, C. AND CARON, M. G.: Delineation of discrete domains for substrate, cocaine and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem. 269: 15985-15988, 1994.
14. GRIFFITHS, R. R., BIGELOW, G. E. AND HENNINGFIELD, J. E.: Similarities in animal and human drug taking behavior. In: Advances in Substance Abuse: Behavioral and Biological Research, ed. by N. K. Mello, pp. 1-90, JAI Press, Greenwich, CT, 1980.
15. HYTTEL, J.: Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 6: 277-295, 1982.
16. JOHANSON, C. E. AND BALSTER, R. L.: A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys. Bull. Narcotics 30: 43-54, 1978.
17. JOHANSON, C. E. AND FISCHMAN, M. W.: The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41: 3-52, 1989.
18. 3H]mazindol binding sites from alkylation by N-ethylmaleimide. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 227: 411-415, 1992.
19. JONES, S. R., GARRIS, P. A. AND WIGHTMAN, R. M.: Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 274: 396-403, 1995.
20. KALIVAS, P. W. AND STEWART. J.: Dopamine transmission in drug- and stress-induced behavioral sensitization Brain Res. Rev. 16: 223-244, 1991.
21. KITAYAMA, S., SHIMADA, S., XU, H., MARKHAM, L., DONOVAN, D. M. AND UHL, G. R.: Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci. U.S.A. 89: 7782-7785, 1992.
22. KOOB, G. F.: Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13: 177-184, 1992.
23. KUHAR, M. J., RITZ, M. C. AND BOJA, J. W.: The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14: 299-302, 1991.
24. MCELVAIN, J. S. AND SCHENK, J. O.: A multi-substrate mechanism of striatal dopamine uptake and its inhibition by cocaine. Biochem. Pharmacol. 43: 2189-2199, 1992.
25. NESTLER, E. J.: Molecular neurobiology of drug addiction. Neuropsychopharmacology 11: 77-87, 1994.
26. NOMIKOS, G. G., DAMSMA, G., WENKSTERN, B. A. AND FIBIGER, H. C.: Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology 2: 273-279, 1989.
27. NOMIKOS, G. G., DAMSMA, G., WENKSTERN, B. A. AND FIBIGER, H. C.: Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum, Neuropsychopharmacology 7: 7-14, 1992.
28. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
29. PERIS, J., BOYSON, S. J., CASS, W. A., CURELLA, P., DWOSKIN, L. P., LARSON, G., LIN, L-H., YASUDA, R. P. AND ZAHNISER, N. R.: Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J. Pharmacol. Exp. Ther. 253: 38-44, 1990.
30. PETTIT, H. O. AND JUSTICE, J. B.: Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol. Biochem. Behav. 34: 899-904, 1989.
31. 3H]cocaine binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 351: 136-145, 1995.
32. 125I]RTI-55. J. Pharmacol. Exp. Ther. 270: 296-309, 1994.
33. ROTHMAN, R. B. AND GLOWA, J. R.: A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development: Focus on GBR 12909. Mol. Neurobiol. 11: 1-19, 1995.
34. ROTHMAN, R. B., MELE, A., REID, A. A., AKUNNE, H. C., GREIG, N., THURKAUF, A., DE COSTA, B. R., RICE, K. C. AND PERT, A.: GBR 12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol. Biochem. Behav. 40: 387-397, 1991.
35. SAADOUNI, S., REFAHI-LYAMANI, F., COSTENTIN, J. AND BONNET, J. J.: Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 268: 187-197, 1994.
36. 3H]mazindol-labelling of dopamine transporter in nucleus accumbens. Eur. J. Pharmacol. 203: 141-144, 1991.
37. SIEGEL, S.: Drug anticipation and drug tolerance. In: The psychopharmacology of addiction, ed. by M. Lader, pp. 73-96, Oxford University Press, New York, 1988.
38. SPYRAKI, C. AND FIBIGER, H. C.: Intravenous self-administration of nomifensine in rats: Implications for abuse potential in humans. Science 212: 1167-1168, 1981.
39. STATHIS, M., SCHEFFEL, U., LEVER, S. Z., BOJA, J. W., CARROLL, F. I. AND KUHAR, M. J.: Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology 119: 376-384, 1995.
40. TELLA, S. R.: Effects of monoamine reuptake inhibitors on cocaine self-administration in rats. Pharmacol. Biochem. Behav. 51: 687-692, 1995.
41. TELLA, S. R.: Possible novel pharmacodynamic action of cocaine: Cardiovascular and behavioral evidence. Pharmacol. Biochem. Behav. 54: 343-354, 1996.
42. TELLA, S. R., LADENHEIM, B., ANDREWS, A. M., GOLDBERG, S. R. AND CADET, J. L.: Differential reinforcing effects of cocaine and GBR-12909: Biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system. J. Neurosci. 16: 7416-7427, 1996.
43. VAN DER ZEE, P., KOGER, H. S., GOOTJES, J. AND HESPE, W.: Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of dopamine uptake. Eur. J. Med. Chem. 15: 363-370, 1980.
44. 125I]iodophenyl)tropane to serotonin and dopamine transporters: Different ionic requirements for substrate and 2β-carbomethoxy-3β-(4-[125I]iodophenyl)tropane binding. Mol. Pharmacol. 43: 264-270, 1993.
45. WEISS, F., HURD, Y. L., UNGERSTEDT, U., MARKOU, A., PLOTSKY, P. M. AND KOOB, G. F.: Neurochemical correlates of cocaine and ethanol self-administration. Ann. NY Acad. Sci. 654: 220-241, 1992.
46. 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J. Neurosci. 14: 2966-2979, 1994.
47. WISE, R. A., NEWTON, P., LEEB, K., BURNETTE, B., POCOCK, D. AND JUSTICE, JR., J. B.: Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology 120: 10-20, 1995.